Evergen is a biotech company that builds on its core technology expertise in animal cloning, transgensis, in vitro fertilization, embryo cryopreservation and embryo transfer.

The recent advancements in animal cloning and related animal embryo biotechnologies have fueled a new revolution in science and society.  There is no longer any doubt of the potential applications of these technologies in agriculture, medicine and basic biological research. 

The Company's mission is to provide quality embryo and animal products and services to various customers by using its leading animal cloning technologies in order to compete in a multi-billion dollar market worldwide.

The Company’s goal is to capitalize on its leading position in somatic cell cattle cloning, in vitro embryo production and cryopreservation while leveraging emerging molecular and cell biology techniques to provide gene targeted non-murine animal models to the biomedical and pharmaceutical community.

In the long term, the Company will continue to invest in research and development to keep its market leading position in embryo biotechnology.